Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible. Unlike limited gene tests, WGS captures an individual’s entire genetic code in one analysis, creating a lifelong genomic health record that can be reinterpreted as new discoveries emerge. This shift positions WGS as a cornerstone for proactive, personalized medicine in the years ahead.
Read more Here
The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths
According to the cdc, heart disease is the leading cause of death in America. Going all the way back to the 1950's. and while people have become familiar with genetic testing for cancer risk.
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.
A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.
Findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems sho
Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale.
A research team from Renton, Wash based Providence has launched an interactive toolkit to help health systems boost equity in medical research.
Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients
Researchers develop framework for health systems to build bridges and engage Black, Latino and American Indian communities in medical research
A new Providence-led study published in Nature offers one of the most detailed looks yet at what actually happens inside the body after a pig kidney is transplanted into a human.
A Cross-Sectional Retrospective Case-Control Study on Predictors of Early Onset Colorectal Cancer in a Multi-State Community Health System.
Providence, Microsoft Research, University of Washington unveil GigaTIME, an AI-powered pathology breakthrough set to transform cancer immunotherapy research
Over 100 leaders, researchers and others from Montana and the Pacific Northwest recently convened for the announcement of a pioneering rural health collaborative from Providence and the University of
Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible
This study includes authors from Providence Genomics in collaboration with Providence Swedish Cancer Institute.
